StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie cost of products sold ($M) ($M)

Form 10-Q / 10-K

QuarterlyAnnual
Latest, FY2025
18,204
Period ended Dec 31, 2025
Change on a year earlier
+7.7%
16,904 in FY2024
History
15 years
Since FY2011
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCost of products sold ($M) ($M)Year on yearSource
FY2025Dec 31, 202518,204+7.7%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 202416,904-17.2%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 202320,415+17.2%Form 10-K (filed 2024-02-20) ↗
FY2022Dec 31, 202217,414-0.2%Form 10-K (filed 2023-02-17) ↗
FY2021Dec 31, 202117,446+13.4%Form 10-K (filed 2022-02-18) ↗
FY2020Dec 31, 202015,387+106.8%Form 10-K (filed 2021-02-19) ↗
FY2019Dec 31, 20197,439-3.6%Form 10-K (filed 2020-02-21) ↗
FY2018Dec 31, 20187,718+9.6%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 20177,042+20.7%Form 10-K (filed 2019-02-27) ↗
FY2016Dec 31, 20165,832+29.6%Form 10-K (filed 2019-02-27) ↗
FY2015Dec 31, 20154,500+1.7%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 20144,426-3.4%Form 10-K (filed 2015-02-20) ↗
FY2013Dec 31, 20134,581+1.6%Form 10-K (filed 2014-02-21) ↗
FY2012Dec 31, 20124,508-2.8%Form 10-K (filed 2014-02-21) ↗
FY2011Dec 31, 20114,639–Form 10-K (filed 2014-02-21) ↗

Cite this data

StockData. (2026). AbbVie Cost of products sold ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_cor

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.